Palaniraja Thandapani / University of Texas MD Anderson Cancer Center
Indian-origin researcher Palaniraja Thandapani has been named to the newest class of Andrew Sabin Family Fellows by the University of Texas MD Anderson Cancer Center, joining 10 other emerging scientists and clinicians making breakthrough discoveries in cancer research and patient care.
Thandapani, who studied at Vellore Institute of Technology, was named in the Basic/Translational Scientists category. He is an assistant professor of Hematopoietic Biology and Malignancy at MD Anderson Cancer Center.
ALSO READ: Stanford professor Saumitra Jha among Social Science Breakthrough finalists
“We are extremely proud to recognize our newest cohort of fellows, part of a growing community of exceptional researchers whose work is shaping the future of oncology,” said Peter W.T. Pisters, M.D., president of UT MD Anderson. “We are grateful to Mr. Sabin and the foundation for their enduring commitment to supporting promising faculty and accelerating breakthroughs that bring us closer to ending cancer.”
The 2026 class of Sabin Family Fellows includes 10 researchers across diverse disciplines who have been identified as rising leaders with the potential to significantly advance cancer prevention, diagnosis and treatment.
Thandapani’s research interests include targeting tRNA deregulation in hematological malignancies.
The 2026 class of Sabin Family Fellows includes 10 researchers who have been identified as rising leaders with the potential to significantly advance cancer prevention, diagnosis and treatment. (1/2) https://t.co/altQ3QOM93 #EndCancer
— UT MD Anderson (@UTMDAnderson) August 17, 2026
Mechanisms regulating mRNA translation account for about 40% of gene expression changes. Protein synthesis is also a major consumer of energy and amino acids in proliferating cells. Tumor growth, the microenvironment and metabolic adaptation can restrict the availability of certain amino acids for protein synthesis, resulting in novel dependencies that can be targeted through dietary or pharmacological interventions.
Established through the generosity of the Andrew Sabin Family Foundation, the Sabin Family Fellowship supports high-impact research across UT MD Anderson, providing funding from a $30 million endowment to early-career faculty advancing impactful discovery as well as translational and clinical research.
Each fellow receives $100,000 over two years, providing the resources and flexibility to focus more fully on innovative research while reducing the burden of securing additional funding.
Discover more at New India Abroad.
ADVERTISEMENT
ADVERTISEMENT
Comments
Start the conversation
Become a member of New India Abroad to start commenting.
Sign Up Now
Already have an account? Login